MENU
+Compare
IPSC
Stock ticker: NASDAQ
AS OF
Sep 17, 01:20 PM (EDT)
Price
$0.50
Change
+$0.01 (+2.04%)
Capitalization
42.95M

IPSC Century Therapeutics Forecast, Technical & Fundamental Analysis

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more

IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IPSC with price predictions
Sep 16, 2025

IPSC saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for IPSC moved out of overbought territory on September 16, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 43 similar instances where the indicator exited the overbought zone. In of the 43 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IPSC entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IPSC's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 11, 2025. You may want to consider a long position or call options on IPSC as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IPSC just turned positive on September 09, 2025. Looking at past instances where IPSC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IPSC advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.202) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.368) is also within normal values, averaging (333.412).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IPSC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPSC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IPSC is expected to report earnings to rise 1.76% to -38 cents per share on November 06

Century Therapeutics IPSC Stock Earnings Reports
Q3'25
Est.
$-0.39
Q2'25
Est.
$-0.38
Q1'25
Beat
by $0.96
Q4'24
Est.
$-0.41
Q3'24
Beat
by $0.08
The last earnings report on August 14 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 27.98K shares outstanding, the current market capitalization sits at 42.95M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
25 N 38th Street
Phone
+1 267 817-5790
Employees
165
Web
https://www.centurytx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MARA17.531.29
+7.94%
MARA Holdings Inc
NTZ3.80N/A
N/A
Natuzzi SpA
STAA27.23-0.44
-1.59%
STAAR Surgical Company
NOW932.01-15.41
-1.63%
SERVICENOW
TOI3.00-0.12
-3.85%
Oncology Institute (The)

IPSC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-1.49%
CRSP - IPSC
56%
Loosely correlated
+5.79%
CABA - IPSC
52%
Loosely correlated
+4.19%
IMNM - IPSC
51%
Loosely correlated
-4.11%
FATE - IPSC
50%
Loosely correlated
-0.53%
ARWR - IPSC
50%
Loosely correlated
+2.62%
More